Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,605,545
-
Total 13F shares
-
89,345,265
-
Share change
-
-84,850
-
Total reported value
-
$8,564,242,432
-
Put/Call ratio
-
240%
-
Price per share
-
$95.85
-
Number of holders
-
385
-
Value change
-
-$6,526,498
-
Number of buys
-
183
-
Number of sells
-
212
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q4 2020
As of 31 Dec 2020 NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) had 385 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 89,345,265 shares of stock of the company.
Largest 10 holders included JANUS HENDERSON GROUP PLC, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Capital International Investors, Bellevue Group AG, STATE STREET CORP, PERCEPTIVE ADVISORS LLC, and RENAISSANCE TECHNOLOGIES LLC.
This table shows 390 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.